F
MRNA icon

F3Logic’s Moderna MRNA Stock Holding History

F3Logic’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$7.08K – 341
2020
Q3 		$7.08K Buy
+100
New +$6.97K 0.18% 115

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

F3Logic's MRNA Position: Q4 2020 in Review

F3Logic sold out of Moderna (MRNA) in Q4 2020, closing a stake of 100 shares — an estimated $7.08K sold.

F3Logic first reported a position in MRNA in Q3 2020 and held it in 1 quarter. The position peaked at $7.08K in Q3 2020. 717 funds tracked by Wall St. Rank hold MRNA as of Q4 2020.

  • F3Logic reported no remaining Moderna position as of Q4 2020 after selling out during the quarter.
  • F3Logic sold 100 Moderna shares in Q4 2020, an estimated $7.08K.
  • F3Logic first reported a position in Moderna in Q3 2020 and held it in 1 quarter.
  • F3Logic's Moderna position peaked at $7.08K in Q3 2020.
  • 717 funds tracked by Wall St. Rank held Moderna as of Q4 2020.

Based on F3Logic's 13F filing for Q4 2020, filed 12 Feb 2021.